US Agencies OK Resumption of J&J COVID Vaccine Use Despite Clot Risk

Government found 15 vaccine recipients who had developed rare blood clots, out of nearly 8 million people given the J&J shot; FDA, CDC decide J&J vaccine use is key to fighting pandemic